Durvalumab Plus Chemotherapy Improves Survival in Advanced Biliary Tract Cancer

Discussion Board Forums Chemotherapy & More Durvalumab Plus Chemotherapy Improves Survival in Advanced Biliary Tract Cancer

Viewing 3 posts - 1 through 3 (of 3 total)
  • Author
    Posts
  • #101466
    bglass
    Moderator

    Hi Keivan,

    I looked at the description of the referenced trial posted on clinicaltrials.gov.  There is no mention of requiring a PDL1 or MSH status to enroll.  Some trials include a more general population then test participants along the way to examine how the treatment being tested affects different groups.  If you search the NCT number (NCT03875235) on the clinicaltrials.gov website, you can see the eligibility and other information associated with the trial.

    Regards, Mary

    #101465
    Keivan
    Participant

    Does it need any genetic test before administration of  Durvalumab? (Like over expression of PDL-1 or MSI-H)

    #101460
    gavin
    Moderator

    Durvalumab Plus Chemotherapy Improves Survival in Advanced Biliary Tract Cancer

    https://www.onclive.com/view/durvalumab-plus-chemotherapy-improves-survival-in-advanced-biliary-tract-cancer

    Thanks to OncLive for this piece.

    Gavin

Viewing 3 posts - 1 through 3 (of 3 total)
  • You must be logged in to reply to this topic.